 ROCKAWAY, NJ, June 30, 2021 GLOBE NEWSWIRE -- electroCore, Inc. the Company, NASDAQ: ECOR, a commercial-stage bioelectronic medicine company, today announced the pricing of an underwritten public offering of 18,000,000 shares of its common stock at a public offering price of 1.00 per share. The gross proceeds of the offering to the Company are expected to be 18.0 million, before deducting the underwriting discounts and commissions and other estimated offering expenses. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 2,700,000 shares of common stock at the public offering price, less underwriting discounts and commissions. 